Haemophilus Test Media (HTM) were prepared from 12 different lots of Mueller-Hinton agar. When tested with Haemophilus influenzae ATCC 49247, most lots were initially rejected because of small zones of inhibition for cefaclor, cefuroxime, and cefamandole disks, whereas five other drugs performed satisfactorily on the 11 lots that supported growth of the control strain. At the same time, tests of Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923 documented the acceptability of these agar media, with or without HTM supplements. The current control limits for cefaclor, cefuroxime, and cefamandole appear to be unrealistic.
In 1987, Jorgensen et al. (5) (5) . The validity of disk tests with HTM agar has been confirmed, and extended studies developed interpretive criteria for additional antimicrobial agents (2, 4 H. influenzae ATCC 49247 was capable of growing on only 11 of the 12 HTM agar plates. The alternative control strain of H. influenzae (ATCC 10211) has more exacting hematin growth requirements, but it grew satisfactorily on all 12 lots of HTM agars. Of the 11 lots that could be tested with H. influenzae ATCC 49247, 10 lots were generally satisfactory when five of the eight study drugs were tested. Table 2 presents the mean results of triplicate tests with each of eight antimicrobial agents performed on each of 11 HTM agar lots. Only three lots (Y-6, Y-7, and Z-10) produced mean zones of inhibition for cefaclor disks that were within the required 14-to 22-mm control limits (9). Zones of inhibition for cefuroxime and cefamandole disks were also within control limits with those three media lots. Seven test media gave substantially smaller zones of inhibition for cefaclor, cefuroxime, and cefamandole disks. Zone diameters around cefotaxime and ceftazidime disks showed less lot-to-lot variability. Two of three media from manufacturer Y (Table 2) gave cefaclor zones that were within the control limits, but on those media, ampicillin inhibition zone diameters were too large to be consistently within control limits. The third lot from that manufacturer (Y-8) gave unacceptably large zones of inhibition for all six P-lactams; only zones of inhibition around chloramphenicol and tetracycline disks were within accepted limits.
In summary, the ampicillin-resistant P-lactamase-negative control strain of H. influenzae (ATCC 49242) was not capable of producing zones of inhibition that consistently fell within the control limits of the National Committee for Clinical Laboratory Standards. Contemporary lots of Mueller-Hinton agar were frequently judged to be unsatisfactory because of small zones of inhibition for cefaclor, cefuroxime, or cefamandole disks. The control strain also frequently appeared to be resistant to cefonicid and loracarbef (data not shown). One might assume that the control strain of H. influenzae is truly resistant to cefaclor, cefuroxime, cefamandole, cefonicid, and loracarbef because of the altered affinity of penicillin-binding proteins that are usually produced by such strains. Consequently, very small zones of inhibition for those drugs are likely to be correct clinically, and media that give small or no zones of inhibition should be preferred and not rejected. If that presumption is correct, only one of our agar lots (lot Y-8) would have been rejected. The National Committee for Clinical Laboratory Standards has recently identified an ampicillin-susceptible strain of H. influenzae (ATCC 49766) specifically for monitoring tests with those five problematic drugs. Zone size limits for that new control strain have been defined and will be reported elsewhere. With that change, many of the media-related inconsistencies that we reported here will no longer be detected because the problematic drug-microorganism combinations will not be tested. However, one must be concerned with the likelihood that rarely encountered (3) clinical isolates of ,B-lactamase-negative, ampicillin-resistant H. influenzae strains may appear to be susceptible to the problematic drugs when they are tested on HTM agars that perform satisfactorily with the alternative ampicillin-susceptible control strain. Continued use of the first control strain of H. influenzae (ATCC 49242) might be advisable, but unusually small zones of inhibition or no zones of inhibition around cefaclor, cefuroxime, cefamandole, cefonicid, or loracarbef disks should be considered the preferred test result.
